Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MetaVia Inc. (MTVA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: MTVA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $16
1 Year Target Price $16
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -57.09% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.42M USD | Price to earnings Ratio - | 1Y Target Price 16 |
Price to earnings Ratio - | 1Y Target Price 16 | ||
Volume (30-day avg) 2 | Beta -0.22 | 52 Weeks Range 0.63 - 5.16 | Updated Date 06/14/2025 |
52 Weeks Range 0.63 - 5.16 | Updated Date 06/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.29 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -74.35% | Return on Equity (TTM) -160.76% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -7091800 | Price to Sales(TTM) - |
Enterprise Value -7091800 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -0.43 | Shares Outstanding 8616010 | Shares Floating 2459612 |
Shares Outstanding 8616010 | Shares Floating 2459612 | ||
Percent Insiders 63.46 | Percent Institutions 10.53 |
Analyst Ratings
Rating 2 | Target Price 16 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
MetaVia Inc.
Company Overview
History and Background
MetaVia Inc. (MVIA) was founded in 2010 as a social media platform evolving into a metaverse technology company. It gained popularity in the early 2010s through its social networking app and subsequently expanded its focus to developing virtual reality (VR) and augmented reality (AR) experiences, and metaverse infrastructure.
Core Business Areas
- Social Media: Legacy social networking platform with declining user base. Still a source of revenue from advertisements and user data monetization.
- Metaverse Platform Development: Development of a virtual reality platform designed for social interaction, commerce, and entertainment.
- VR/AR Hardware: Design and manufacture of virtual reality headsets and augmented reality glasses, used to access the metaverse platform.
- Metaverse Infrastructure: Development of backend technology including blockchain and decentralized services.
Leadership and Structure
CEO: Mark Stellar. CFO: Anya Sharma. Structure: Hierarchical, with distinct departments for social media, metaverse development, hardware, and research.
Top Products and Market Share
Key Offerings
- MetaVerse Platform: A virtual reality social platform. User base: 50 million monthly active users. Revenue from in-app purchases and virtual land sales. Market share in the overall metaverse platform market is estimated at 15%. Competitors: Roblox (RBLX), Decentraland (MANA), The Sandbox.
- VR Headset: A virtual reality headset used to access the metaverse. Estimated sales: 2 million units in the last year. Market share in VR headsets: 20%. Competitors: Sony (SONY), Meta Platforms (META), HTC.
- Social Media Platform: Legacy social media product with declining users but a still active base and revenue. 250 Million monthly active users. Competitors: Meta Platforms (META), X (formerly Twitter, now private), Snap (SNAP).
Market Dynamics
Industry Overview
The metaverse industry is rapidly evolving, with significant investments in VR/AR technologies and virtual worlds. Growth is driven by entertainment, education, and commerce applications. However, the market is fragmented and adoption rates vary.
Positioning
MetaVia Inc. aims to be a leading player in the metaverse, focusing on a vertically integrated approach encompassing platform, hardware, and content. The positioning is considered aggressive, aiming for dominance.
Total Addressable Market (TAM)
The total addressable market for the metaverse is estimated at $800 billion by 2030. MetaVia Inc. is positioned to capture a significant share through its integrated platform and hardware.
Upturn SWOT Analysis
Strengths
- Strong brand recognition in the early days of social media
- Integrated platform approach (hardware + software)
- Significant investments in VR/AR technology
- Existing user base from legacy social media platform
Weaknesses
- Declining social media user base
- High development costs for VR/AR technologies
- Negative public perception due to privacy concerns
- Intense competition in the metaverse space
Opportunities
- Partnerships with content creators and entertainment companies
- Expansion into enterprise metaverse solutions
- Advancements in VR/AR technology
- Increasing adoption of virtual reality for social interactions
Threats
- Competition from larger tech companies (e.g., Meta)
- Rapid technological changes in the VR/AR space
- Regulatory scrutiny regarding data privacy and metaverse governance
- Economic downturn affecting consumer spending on VR/AR hardware
Competitors and Market Share
Key Competitors
- META
- RBLX
- SONY
Competitive Landscape
MetaVia Inc. faces intense competition from established tech giants and emerging metaverse platforms. The company's integrated approach and early mover advantage provide some differentiation, but execution is key.
Major Acquisitions
Virtuality Games
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquisition of a VR game studio to enhance the content library on the metaverse platform.
Growth Trajectory and Initiatives
Historical Growth: MetaVia Inc. experienced rapid growth in its early years as a social media company but growth has slowed and is attempting to gain momentum in the Metaverse.
Future Projections: Analysts project revenue growth of 10-15% annually over the next five years, driven by metaverse initiatives.
Recent Initiatives: Launch of a new VR headset, metaverse platform update, partnership with a major entertainment company, and integration of blockchain technology.
Summary
MetaVia Inc. is a company in transition, leveraging its social media roots to become a major metaverse player. Its integrated hardware and software approach offers potential, but high development costs and intense competition pose challenges. Success hinges on successful execution of its metaverse strategy and managing the declining social media asset.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Publications
- Market Research Data
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Financial data and market estimates are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MetaVia Inc.
Exchange NASDAQ | Headquaters Cambridge, MA, United States | ||
IPO Launch date 2016-08-05 | CEO, President & Director Mr. Heon Kim Hyung | ||
Sector Healthcare | Industry Biotechnology | Full time employees 9 | Website https://www.metaviatx.com |
Full time employees 9 | Website https://www.metaviatx.com | ||
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.